Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for ...

Since 2016, the FDA has received more than 25 reports of confusion between the nasal solution and injectable products, including one report in 2024 of a patient who was injected with the nasal ...

Continue to breathe calmly through your mouth. The saltwater solution will fill your nasal passages and sinuses, cross behind the nasal septum and exit from your lower nostril into the sink.

Drug firm Lupin Ltd on Monday (February 10) said it has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for ipratropium ...

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...

In this case, epistaxis is often associated with unilateral nasal obstruction ... (xylocaine naphazoline), left in place for a few minutes. Local anaesthesia facilitates examination and subsequent ...

A pimple-like bump or sore inside the nose can sometimes be due to nasal vestibulitis or nasal folliculitis. It is a bacterial infection that can develop when hair follicles become infected ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

When a cold leaves you stuffed up, you can get fast relief from a nasal spray. But take a minute to learn the different types and how to use them. It can make all the difference in effectively ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.